Dailypharm Live Search Close

SK bioscience collaborates with the Doherty Institute

By | translator Choi HeeYoung

23.06.27 11:38:58

°¡³ª´Ù¶ó 0
The Peter Doherty Institute for Infection and Immunity, the world's top 3 source of flu strains

Taking the lead in global flu prevention and response, development of a new vaccine platform

"We will build a global network to take the lead in responding to the next pandemic"

 ¡ãFrom left, SK Bioscience CEO Ahn Jae-yong, Australia

SK bioscience announced on the 27th that it had signed a research cooperation agreement with the Peter Doherty Institute for Infection and Immunity in Australia for global influenza prevention and response. The Peter Doherty Institute for Infection and Immunity is an infectious disease research institute affiliated with the University of Melbourne, Australia. It is the World Health Organization (WHO) Influenza Collaboration Center and one of the world's three major sources of influenza strains. The signing ceremony was held at SK Bioscience Pangyo headquarters with Professor Sharon Lewin, Director of The Peter Doherty Institute for Infection and Immunity and Head of the Department of Infectious Diseases at the Univers

(same@dailypharm.com)
If you want to see the full article, please JOIN US (click)